JP-1302: a new tool to shed light on the roles of alpha2C-adrenoceptors in brain

  • Br J Pharmacol. 2007 Feb;150(4):381-2. doi: 10.1038/sj.bjp.0707007.
M D Tricklebank  1
Affiliations
  • 1. Discovery Biology, Eli Lilly and Co. Ltd, Erl Wood Manor, Windlesham, Surrey, UK. [email protected]
PMID: 17220912 DOI: 10.1038/sj.bjp.0707007
Abstract

The discovery of JP-1302 as a selective, high affinity antagonist at the alpha2C-adrenoceptor will enable researchers to probe the functional role and address the therapeutic utility of this potentially highly important adrenoceptor subtype.

Products